OPKO Health (OPK) Misses Q4 EPS by 4c

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $221.9 million versus the consensus estimate of $245.3 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss